Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![wegro_app Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1787088114588209152.png) Wegro App [@wegro_app](/creator/twitter/wegro_app) on x 10.3K followers
Created: 2025-06-29 14:30:21 UTC

Torrent Pharmaceuticals Ltd. (Torrent) will acquire a controlling stake in J.B. Chemicals & Pharmaceuticals Ltd. (JB Pharma) from KKR. The deal is valued at ₹25,689 crore (fully diluted basis) and will be executed in two phases. First, Torrent will acquire a XXXXX% equity stake for ₹11,917 crore (₹1,600 per share), followed by a mandatory open offer for XX% of JB Pharma shares at ₹1,639.18 per share. 🤝 Torrent also intends to acquire up to XXXX% of equity shares from JB Pharma employees.

- 𝗔𝗰𝗾𝘂𝗶𝘀𝗶𝘁𝗶𝗼𝗻 𝗗𝗲𝘁𝗮𝗶𝗹𝘀:
  ▪ Torrent will acquire XXXXX% stake from Tau Investment Holdings Pte. Ltd. (promoter of Target Company) for ₹11,917 crore.
  ▪ Potential acquisition of up to XXXX% equity shares from certain employees.
  ▪ Open offer for XXXXX% of the expanded share capital.
  ▪ The share purchase agreement is dated June 29, 2025.

- 𝗠𝗲𝗿𝗴𝗲𝗿:
  ▪ The merger will be through a scheme of amalgamation.
  ▪ Shareholders of JB Pharma will receive XX shares of Torrent for every XXX shares held.

- 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗥𝗮𝘁𝗶𝗼𝗻𝗮𝗹𝗲:
  ▪ Access to a fast-growing India franchise.
  ▪ Entry into untapped therapeutic areas.
  ▪ Strengthens market share in the IPM.
  ▪ Platform diversification into the CDMO segment.
  ▪ Consolidation in key international markets.

- 𝗙𝗶𝗻𝗮𝗻𝗰𝗶𝗮𝗹𝘀 𝗼𝗳 𝗝𝗕 𝗖𝗵𝗲𝗺𝗶𝗰𝗮𝗹𝘀 & 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 (𝗧𝗮𝗿𝗴𝗲𝘁 𝗖𝗼𝗺𝗽𝗮𝗻𝘆) 𝗮𝘀 𝗼𝗻 𝗠𝗮𝗿𝗰𝗵 𝟯𝟭, 𝟮𝟬𝟮𝟱:
  ▪ Turnover: ₹3,918 crore.
  ▪ Net worth: ₹3,433.32 crore.

- 𝗔𝗽𝗽𝗿𝗼𝘃𝗮𝗹𝘀:
  ▪ Subject to CCI and shareholder approvals.

- 𝗧𝗶𝗺𝗲𝗹𝗶𝗻𝗲:
  ▪ Share Acquisition expected to be completed within X months.
  ▪ Open Offer will be completed in accordance with the Takeover Regulations.

📊 TORRENT PHARMACEUTICALS LTD | 🏷️ Acquisition

🌐 Details:

⚡️AI-driven WhatsApp updates - Try FREE 👉


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1939330602723098635/c:line.svg)

**Related Topics**
[stocks](/topic/stocks)
[$torntpharmns](/topic/$torntpharmns)

[Post Link](https://x.com/wegro_app/status/1939330602723098635)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

wegro_app Avatar Wegro App @wegro_app on x 10.3K followers Created: 2025-06-29 14:30:21 UTC

Torrent Pharmaceuticals Ltd. (Torrent) will acquire a controlling stake in J.B. Chemicals & Pharmaceuticals Ltd. (JB Pharma) from KKR. The deal is valued at ₹25,689 crore (fully diluted basis) and will be executed in two phases. First, Torrent will acquire a XXXXX% equity stake for ₹11,917 crore (₹1,600 per share), followed by a mandatory open offer for XX% of JB Pharma shares at ₹1,639.18 per share. 🤝 Torrent also intends to acquire up to XXXX% of equity shares from JB Pharma employees.

  • 𝗔𝗰𝗾𝘂𝗶𝘀𝗶𝘁𝗶𝗼𝗻 𝗗𝗲𝘁𝗮𝗶𝗹𝘀: ▪ Torrent will acquire XXXXX% stake from Tau Investment Holdings Pte. Ltd. (promoter of Target Company) for ₹11,917 crore. ▪ Potential acquisition of up to XXXX% equity shares from certain employees. ▪ Open offer for XXXXX% of the expanded share capital. ▪ The share purchase agreement is dated June 29, 2025.

  • 𝗠𝗲𝗿𝗴𝗲𝗿: ▪ The merger will be through a scheme of amalgamation. ▪ Shareholders of JB Pharma will receive XX shares of Torrent for every XXX shares held.

  • 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗥𝗮𝘁𝗶𝗼𝗻𝗮𝗹𝗲: ▪ Access to a fast-growing India franchise. ▪ Entry into untapped therapeutic areas. ▪ Strengthens market share in the IPM. ▪ Platform diversification into the CDMO segment. ▪ Consolidation in key international markets.

  • 𝗙𝗶𝗻𝗮𝗻𝗰𝗶𝗮𝗹𝘀 𝗼𝗳 𝗝𝗕 𝗖𝗵𝗲𝗺𝗶𝗰𝗮𝗹𝘀 & 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀 𝗟𝗶𝗺𝗶𝘁𝗲𝗱 (𝗧𝗮𝗿𝗴𝗲𝘁 𝗖𝗼𝗺𝗽𝗮𝗻𝘆) 𝗮𝘀 𝗼𝗻 𝗠𝗮𝗿𝗰𝗵 𝟯𝟭, 𝟮𝟬𝟮𝟱: ▪ Turnover: ₹3,918 crore. ▪ Net worth: ₹3,433.32 crore.

  • 𝗔𝗽𝗽𝗿𝗼𝘃𝗮𝗹𝘀: ▪ Subject to CCI and shareholder approvals.

  • 𝗧𝗶𝗺𝗲𝗹𝗶𝗻𝗲: ▪ Share Acquisition expected to be completed within X months. ▪ Open Offer will be completed in accordance with the Takeover Regulations.

📊 TORRENT PHARMACEUTICALS LTD | 🏷️ Acquisition

🌐 Details:

⚡️AI-driven WhatsApp updates - Try FREE 👉

XXX engagements

Engagements Line Chart

Related Topics stocks $torntpharmns

Post Link

post/tweet::1939330602723098635
/post/tweet::1939330602723098635